✦ LIBER ✦

Clonidine transdermal patches for use in outpatient opiate withdrawal

✍ Scribed by Spencer, L

Book ID: 122704291
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 555 KB
Volume: 6
Category: Article
ISSN: 0740-5472
DOI: 10.1016/0740-5472(89)90038-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Comparison of Clonidine and Buprenorph

A Comparison of Clonidine and Buprenorphine in the Outpatient Treatment of Opiate Withdrawal

✍ Michael I. Fingerhood; Michele R. Thompson; Donald R. Jasinski 📂 Article 📅 2001 🏛 Haworth Press Inc 🌐 English ⚖ 47 KB

Utility of sweat patch testing for drug

Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence

✍ Marek C. Chawarski; David A. Fiellin; Patrick G. O'Connor; Mathew Bernard; Richa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Cotinine replacement levels for a 21 mg/

Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting

✍ Peter Gariti; Arthur I. Alterman; Wayne Barber; Navjyot Bedi; Gary Luck; Avital 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 90 KB

PRS35 COMPARISON OF PATIENT REPORTED OUT

PRS35 COMPARISON OF PATIENT REPORTED OUTCOMES BASED ON THE MINNESOTA NICOTINE WITHDRAWAL SCALE (MNWS) USING ABSTINENCE PROFILES IN TREATMENTS WITH VARENICLINE AND TRANSDERMAL NICOTINE PATCH (NRT)

✍ Marton, JP; Zou, KH; Russ, C; Willke, RJ 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Three-year follow-up of the use of trans

Three-year follow-up of the use of transdermal 17β-estradiol matrix patches for the prevention of bone loss in early postmenopausal women

✍ P.D. Delmas; B. Pornel; D. Felsenberg; J.A. Stakkestad; S. Radowicki; P. Garnero 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Assessing the cost-effectiveness of the

Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models

✍ Balázs Nagy; Alan Brennan; Ágnes Brandtmüller; Simu K. Thomas; Sean D. Sullivan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

Assess long-term cost-effectiveness of rivastigmine patch in Alzheimer's disease (AD) management in the UK, using cognitive and functional models based on clinical trial efficacy data. Methods: Incremental costs and Quality Adjusted Life Years (QALYs) associated with rivastigmine patch and capsule t